Congress trades
Seagen Inc. (SGEN)
About Seagen Inc.
from the company's filings and listing- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Chief executive
- David R. Epstein
- Employees
- 3,256
- Listed since
- Mar 9, 2001
- Market value
- $43.2B
- Price to earnings
- -
- Earnings per share
- -$3.30
- Dividend yield
- -
Earnings
6 reported quarters| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q3 FY2023reported Nov 1, 2023 | -$1.15 | -$0.71 | $648.6M | $634.1M | EPS missRevenue beat |
| Q2 FY2023reported Aug 2, 2023 | -$1.13 | -$0.78 | $603.8M | $559.9M | EPS missRevenue beat |
| Q1 FY2023reported Apr 27, 2023 | -$0.93 | -$0.82 | $519.7M | $517.0M | EPS missRevenue in line |
| Q4 FY2022reported Feb 15, 2023 | -$0.80 | -$1.02 | $528.1M | $466.0M | EPS beatRevenue beat |
| Q3 FY2022reported Oct 27, 2022 | -$1.03 | -$0.92 | $510.3M | n/a | EPS missRevenue n/a |
| Q2 FY2022reported Jul 28, 2022 | -$0.73 | -$0.82 | $497.5M | n/a | EPS beatRevenue n/a |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Congress trades in SGEN
12 disclosures of 12 on record · median 27d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +6.6%S&P +14.6% · vs S&P 500 -8.0% | Oct 27, 2023 | Nov 11, 2023 | 15d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +16.4%S&P +8.7% · vs S&P 500 +7.7% | Jun 26, 2023 | Jul 11, 2023 | 15d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +18.3%S&P +12.5% · vs S&P 500 +5.9% | May 19, 2023 | Jun 11, 2023 | 23d |
| Daniel S. Goldman | Stock | Purchase | $1,001 - $15,000 | +29.0%S&P +16.3% · vs S&P 500 +12.6% | Mar 6, 2023 | Apr 17, 2023 | 42d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | +68.2%S&P +28.3% · vs S&P 500 +39.9% | Oct 17, 2022 | Nov 10, 2022 | 24d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +90.2%S&P +8.3% · vs S&P 500 +81.9% | Feb 18, 2022 | Mar 18, 2022 | 28d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +71.9%S&P +5.3% · vs S&P 500 +66.6% | Jan 20, 2022 | Feb 8, 2022 | 19d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +62.2%S&P -0.1% · vs S&P 500 +62.3% | Jan 12, 2022 | Feb 8, 2022 | 27d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +54.6%S&P +13.2% · vs S&P 500 +41.4% | May 17, 2021 | Jun 15, 2021 | 29d |
| Josh GottheimerJointFiled late | Stock | Purchase | $1,001 - $15,000 | +35.3%S&P +43.2% · vs S&P 500 -7.9% | Aug 3, 2020 | Sep 20, 2020 | 48d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | +66.7%S&P +61.9% · vs S&P 500 +4.8% | Apr 30, 2020 | May 13, 2020 | 13d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | +90.7%S&P +39.8% · vs S&P 500 +50.9% | Feb 18, 2020 | Mar 16, 2020 | 27d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 6, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Questions
Which members of Congress have traded SGEN?
Josh Gottheimer, Daniel S. Goldman, Ro Khanna disclosed SGEN transactions in the filings shown here.
How quickly are SGEN trades disclosed?
Congressional disclosures took a median of 27 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.